Company

EverImmune

Research Services Villejuif, Val-de-marne, Fr 4 employees

Employees: 4

www.everimmune.com LinkedIn Crunchbase

EverImmune Overview

Headquarters: Villejuif, Val-de-marne, Fr
Website: www.everimmune.com
Industry: Research Services
Employees: 4
Funding: 3.7M
NAICS: Scientific Research and Development Services

Research and Development in the Physical, Engineering, and Life Sciences

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Keywords

Harnessing the microbiome for the development of diagnosis and therapeutic tools in cancer !

About EverImmune

EverImmune is a biotechnology company specialized in the development of live biotherapeutic products in the field of microbiota oncology. It harnesses the gut microbiota for the development of a unique approach aiming to restore the response of Immune Checkpoint Inhibitors (ICIs) in cancer patients. The company is developing Oncobax AK, a Live Biotherapeutic Product (LBP) used as an oral adjuvant to anticancer immunotherapies, designed to safely boost the immune system and restore sensitivity to immunotherapies in primary resistance settings. The company also develops other bacteria in its pipeline for use in the treatment of different types of cancer. Established in 2016, by co-founders Pr. Laurence Zitvogel and Dr. Romain Daillere, everImmune is a spinoff from Gustave Roussy (Paris, France). The company is part of ONCOBIOME, the first European program dedicated to microbiome and cancer, funded by the European Union.

EverImmune Contact Details

People in AeroLeads: 3

EverImmune Org Chart

Sample employees and titles

Name	Title	Location	Contact
Alain Thibault	Chief Medical Officer at Everimmune		View
Alain Thibault	Oncology Drug Development		View
Gladys Ferrere	Immunology, Microbiota, Diseases	Greater Paris Metropolitan Region, France	View